There’s been plenty of excitement surrounding the newly updated American menopause treatment guidelines, released in October 2026 by the American College of Obstetricians and Gynecologists (ACOG).
And while I’m delighted to see menopause receiving more attention, I think it’s important to ask a question:
How much of this information is actually new?
As a naturopathic doctor practicing in Burlington, Ontario, with more than 15 years of clinical experience, I’ve been following the evolving research on perimenopause, menopause and women’s health for years.
One thing that sometimes gets lost in the excitement surrounding new medical guidelines is that updated recommendations don’t necessarily represent new scientific discoveries.
In fact, many of these recommendations were already part of Canadian menopause treatment guidelines published back in 2021.
Let’s take a closer look.
Why new medical guidelines don’t always mean new discoveries
Clinical practice guidelines generally follow scientific research rather than introduce it.
Before a treatment recommendation makes its way into a formal guideline, researchers may have spent years studying its effectiveness, safety and limitations.
Evidence accumulates, studies are evaluated, and professional organizations eventually update their recommendations to reflect the available research.
This process can take years.
That’s why it’s important to distinguish between newly published recommendations and genuinely new scientific evidence.
Guideline updates are valuable. They help standardize healthcare and encourage evidence-based treatment. But a new publication date doesn’t automatically mean a major breakthrough has occurred.
What did the new American menopause guidelines recommend?
The October 2026 ACOG guideline focuses on three areas of menopause care:
- Vasomotor symptoms, including hot flashes and night sweats
- Sleep disturbances
- Mood symptoms
Among the recommendations are systemic menopausal hormone therapy for eligible women experiencing hot flashes, night sweats and associated sleep disturbances; nonhormonal prescription medications for appropriate patients; and selected nonpharmacological approaches.
The guideline also emphasizes individualized treatment decisions based on a woman’s symptoms, medical history, preferences and potential risks.
These are important recommendations.
But many are not new.
What did Canadian menopause guidelines already say in 2021?
The Society of Obstetricians and Gynaecologists of Canada (SOGC) published comprehensive menopause guidelines in 2021, covering many of the same principles.
1. Hormone therapy is the most effective treatment for hot flashes and night sweats.
This was already a strong recommendation in the Canadian guidelines.
2. Hormone therapy should be individualized.
Canadian recommendations already emphasized evaluating each woman’s symptoms, personal and family medical history, potential risks and treatment preferences.
3. Timing matters.
Canadian guidelines recognized that systemic hormone therapy can generally be initiated safely in appropriately selected women younger than 60 or within 10 years of menopause, provided there are no contraindications.
4. Nonhormonal treatment options matter, too.
The Canadian guidelines discussed prescription alternatives for women who cannot or prefer not to use hormone therapy.
5. Sleep and mood symptoms deserve attention.
Canada’s 2021 guidance also addressed menopause-related insomnia, mood disturbances, depression and cognitive concerns.
It recognized that night sweats can contribute to disrupted sleep and that treatment should account for other possible causes.
In other words, a considerable amount of what is now generating excitement online was already established in Canadian clinical guidance five years ago.
So what is different in the new American guidelines?
There are some interesting developments.
One that caught my attention involves acupuncture.
The new ACOG guideline conditionally recommends acupuncture as an option for reducing hot flashes and improving menopause-related sleep and mood symptoms.
Importantly, ACOG describes the supporting evidence as low quality. This means acupuncture should not be portrayed as equally proven or effective as hormone therapy.
As a naturopathic doctor who incorporates acupuncture into patient care, I find this noteworthy, particularly because earlier professional guidelines have been more cautious about recommending acupuncture specifically for menopausal hot flashes.
The new American guidance also incorporates newer nonhormonal medication classes that were not part of the original 2021 Canadian recommendations.
Another interesting distinction concerns mood.
The Canadian 2021 guideline recognized some evidence that hormone therapy may have antidepressant effects during perimenopause, while continuing to recommend established depression treatments as first-line care.
The new ACOG guideline takes a more cautious position, concluding that evidence remains insufficient to recommend hormone therapy specifically to treat menopause-related depressive symptoms.
These differences illustrate why guidelines should be interpreted carefully rather than reduced to headlines.
What does this mean for women experiencing perimenopause or menopause?
The takeaway is not that every woman should begin hormone therapy, nor that one treatment approach is right for everyone.
Rather, women deserve an individualized discussion about the treatment options supported by current evidence.
For some, menopausal hormone therapy may provide meaningful symptom relief.
For others, nonhormonal medications, cognitive behavioural therapy, or selected complementary approaches may have a role.
Lifestyle factors such as resistance training, cardiovascular exercise, nutrition and sleep habits also matter for overall midlife health, although their benefits should not be confused with proven treatment effects for every menopause symptom.
It’s equally important not to attribute every new symptom in midlife to fluctuating hormones. Thyroid conditions, sleep disorders, mental health conditions and other medical issues can produce overlapping symptoms and may require further evaluation.
Menopause care in Burlington and Oakville, Ontario
For women in Burlington, Oakville and the surrounding communities, informed menopause care doesn’t need to begin with the latest American headline.
Canadian clinical guidelines have supported individualized, evidence-based menopause treatment for years.
At my Burlington naturopathic practice, I work with women navigating perimenopause and menopause, helping them better understand their symptoms, available treatment options and broader health considerations.
My approach includes assessment, education, hormone therapy discussions where appropriate, nutrition and lifestyle counselling, and acupuncture when clinically indicated.
The goal is not simply to manage a hot flash, but to consider the whole person and support informed healthcare decisions through midlife and beyond.
The bottom line
I’m genuinely pleased that menopause is receiving more clinical and public attention. For too long, many women’s symptoms have been overlooked or inadequately addressed.
But it’s worth remembering:
New guidelines don’t necessarily mean new science.
Sometimes, they simply reflect years of research finally being incorporated into formal recommendations.
And in this case, Canadian menopause guidance was already addressing many of these important treatment principles back in 2021.
If you’re experiencing perimenopause or menopause symptoms and would like to better understand your options, I welcome you to book a consultation at my Burlington practice or virtually from elsewhere in Ontario.
Simply Healthy, Simply Strong.
References
- American College of Obstetricians and Gynecologists. Management of Menopause-Related Vasomotor, Sleep, and Mood Symptoms. Obstetrics & Gynecology. 2026. https://doi.org/10.1097/AOG.0000000000006428
- Society of Obstetricians and Gynaecologists of Canada. Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. Journal of Obstetrics and Gynaecology Canada. 2021. https://doi.org/10.1016/j.jogc.2021.08.003
- Society of Obstetricians and Gynaecologists of Canada. Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. Journal of Obstetrics and Gynaecology Canada. 2021.
- Canadian Menopause Society. Clinical Practice Guidelines. https://www.canadianmenopausesociety.org/professionals/menopause-hub/guidelines/
This article is intended for general educational purposes and does not replace individualized assessment, diagnosis or treatment recommendations from a qualified healthcare professional.
